Aripiprazole for the Augmentation of Antidepressant Therapy: An Observational, Outpatients Study in Inadequate Responders Diagnosed With Major Depressive Disorder.
Phase of Trial: Phase IV
Latest Information Update: 09 Apr 2015
At a glance
- Drugs Aripiprazole (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 20 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Sep 2011 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History